Apollo Hospitals Enterprise Limited — Updates, 30-06-2025: Scheme of Arrangement

Apollo Hospitals Enterprise Limited has announced a board meeting on the approval of a composite scheme involving the demerger of its omni-channel pharmacy and digital health business into a new entity ("NewCo"), followed by the merger of its material subsidiaries, Apollo Healthco Limited and Keimed Private Limited, into NewCo. This restructuring will consolidate pharmacy distribution and digital health platforms under one listed company, targeting INR 16,300 Cr revenue in FY25 and aiming for INR 25,000 Cr by FY27. Shareholders of AHEL will receive shares in the new entity at an exchange ratio of 195.2 NewCo shares for every 100 AHEL shares, enabling direct value realization. NewCo will acquire 100% of Apollo Pharmacies via additional stake acquisition in Apollo Medicals Pvt. Ltd., enhancing retail integration and customer reach across India’s largest omni-channel healthcare ecosystem. The arrangement aims to unlock growth, operational synergies, and capital allocation efficiencies, with the new entity expected to be listed within 18-21 months.